218 related articles for article (PubMed ID: 17448953)
1. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage.
Chaidos A; Kanfer E; Apperley JF
Best Pract Res Clin Haematol; 2007 Jun; 20(2):125-54. PubMed ID: 17448953
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
3. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
[No Abstract] [Full Text] [Related]
4. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
5. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1992; 13():327-48. PubMed ID: 1389914
[No Abstract] [Full Text] [Related]
6. DLI or second transplant.
Greinix HT
Ann Hematol; 2002; 81 Suppl 2():S34-5. PubMed ID: 12611068
[TBL] [Abstract][Full Text] [Related]
7. Risk assessment in haematopoietic stem cell transplantation.
Gratwohl A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):119-24. PubMed ID: 17448952
[No Abstract] [Full Text] [Related]
8. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
[TBL] [Abstract][Full Text] [Related]
9. Total-body irradiation--role and indications: results from the German Registry for Stem Cell Transplantation (DRST).
Heinzelmann F; Ottinger H; Müller CH; Allgaier S; Faul C; Bamberg M; Belka C
Strahlenther Onkol; 2006 Apr; 182(4):222-30. PubMed ID: 16622624
[TBL] [Abstract][Full Text] [Related]
10. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
11. Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis.
Palandri F; Amabile M; Rosti G; Bandini G; Benedetti F; Usala E; Angelucci E; Tiribelli M; Fanin R; Martinelli G; Baccarani M
Bone Marrow Transplant; 2007 Feb; 39(3):189-91. PubMed ID: 17211436
[No Abstract] [Full Text] [Related]
12. [Stem cells in hematology and oncology].
Goldschmidt H; Egerer G; Fruehauf S; Ho AD
Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
[TBL] [Abstract][Full Text] [Related]
13. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
[No Abstract] [Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia.
Weisdorf D; Forman S
Cancer Treat Res; 2009; 144():441-54. PubMed ID: 19779879
[No Abstract] [Full Text] [Related]
15. [Treatment of acute and chronic leukemias].
Mandelli F; Montefusco E
Recenti Prog Med; 1999 Nov; 90(11):605-12. PubMed ID: 10608151
[TBL] [Abstract][Full Text] [Related]
16. Leukemia and myelomatosis.
Catovsky D
Cancer Chemother Biol Response Modif; 1987; 9():134-64. PubMed ID: 3079401
[No Abstract] [Full Text] [Related]
17. Current thinking in the management of leukaemia.
Szer J
Aust Fam Physician; 1994 Aug; 23(8):1500-5. PubMed ID: 7526835
[TBL] [Abstract][Full Text] [Related]
18. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1994; 15():391-412. PubMed ID: 7779590
[No Abstract] [Full Text] [Related]
19. Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies.
Lassaletta A; Ramírez M; Montero JM; González-Vicent M; Balas A; Madero L; Díaz MA
Leukemia; 2005 Apr; 19(4):504-6. PubMed ID: 15729381
[No Abstract] [Full Text] [Related]
20. Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment.
Dazzi F; Fozza C
Best Pract Res Clin Haematol; 2007 Jun; 20(2):311-27. PubMed ID: 17448964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
